ORTEXORTEX News
Tracking HOMB? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HO
Trader NoteHOMB

HOMB Shorts Hold Ground After Earnings Beat

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 22:25

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Home BancShares has rallied 3.6% on the week to $29.39 following a better-than-expected Q3 print, yet short sellers have not blinked: positions have continued to build even as the stock recovered.

The short interest story has changed in tone since the pre-earnings previews. What was a pre-results build is now a post-results hold. Short interest has climbed further to 5.3% of the free float, up 20% over the past month and still rising, adding roughly 93,000 shares net on Tuesday alone. Bears accumulated through the earnings release rather than covering into it. That persistence is notable. At the same time, the borrow market offers nothing to a squeeze case. Availability is at 2,146%, meaning there are more than 21 shares available for every one currently lent out, down from over 3,500% in early October as the short build tightens the pool modestly, but still exceptionally loose. Borrowing costs are 0.49%, up 21% on the week but still negligible in absolute terms. Options traders are even less alarmed: the put/call ratio is at 0.09, below its 20-day average of 0.12 and near the low end of its 52-week range. The setup reads as a measured fundamental disagreement rather than a momentum short or a squeeze-in-waiting.

The Street's immediate reaction to earnings was to trim rather than upgrade. Citigroup's Benjamin Gerlinger cut his target to $31 from $32 on Monday while keeping a Neutral rating. Piper Sandler moved similarly last Thursday, lowering to $34 from $36 while maintaining Overweight. Both cuts came after the Q3 print, suggesting analysts viewed the beat as solid but not sufficient to sustain prior targets. The consensus mean sits at $32.75 against a current price of $29.39, implying roughly 11% upside from here on the average view. The bull case centres on the Q3 EPS beat of $0.02 above estimates, driven by stronger net interest income and zero provision expense, alongside an asset-sensitive balance sheet that management argues benefits from rate repricing on a $7 billion variable-rate loan book. The bear case is harder to dismiss: loans fell at a 5% annualised rate in the quarter, total deposits dropped 7.5%, and the company still has roughly 2.2 million shares left to repurchase from the MCB deal issuance, absorbing capital that could otherwise fund growth. The P/E multiple is around 11.4x and price-to-book near 1.2x, both reasonable for a regional bank of this quality, though the EPS momentum scores rank in the bottom third of the universe on both 30-day and 90-day measures.

Institutional ownership tells a broadly constructive story. BlackRock holds 12.9% of shares and added nearly 1.9 million shares in the quarter ended September 30. State Street added 903,000 shares over the same period. T. Rowe Price added 598,000. These are index and passive-adjacent flows in part, but the direction is consistent: the largest holders have been buyers. Insider activity tells a less encouraging story. The 90-day net is negative at minus 29,000 shares and minus $895,000 in value, driven by open-market sales from a director and the Centennial Bank CEO in August, both at prices above the current level. None of those trades were under 10b5-1 plans, giving them more signal weight than a pre-programmed sale would carry.

The FDIC call report data captured by ORTEX Alt Data shows total assets at Home BancShares' insured bank charters have risen for three consecutive quarters to $24.7 billion, and total deposits at the chartered level have also risen for three consecutive quarters to $19.7 billion as of April 2026. This is worth noting as context against the Q3 consolidated figures showing deposit declines: the FDIC series and the consolidated reporting do not always move in lockstep, and the Alt Data series has not yet been tested as a leading indicator of the company's reported figures, so no directional inference follows from it.

The week's peer moves offer a useful cross-check. UBSI gained 3.2% on the week and FNB added 3.6%, broadly in line with HOMB's 3.6% recovery. The cohort moved together, which suggests the post-earnings lift in HOMB was as much a sector bid as a company-specific re-rating. What to watch next is whether short sellers begin to cover now that the earnings event has passed without a credit-quality scare, or whether the bear case on loan growth and the buyback overhang keeps positions elevated into year-end.

Stocks in this article

See the live data behind this article on ORTEX.

Open HOMB on ORTEX →

How this article was generated

Generated
21 Oct 2026, 22:26
Data as of
21 Oct 2026, 22:25
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.